Pfizer 3Q Revenues: $12.0 billion (-2%) 3Q Earnings: $761 million (-77%) YTD Revenues: $35.6 billion (-1%) YTD Earnings: $5.4 billion (-45%) Comments: 3Q Pharma sales dropped 4% to $11.0 billion. Ongoing generic erosion from Zoloft (June 2006) and Norvasc (March 2007) hurt revenues for 3Q and YTD. Sales for those products dropped from $1.6 billion in 3Q06 to $764 million in 3Q07 and $5.5 billion YTD06 to $2.8 billion in YTD07. Lipitor sales decreased 5% to $3.2 billion due to comp...